Feeling Tired on Mounjaro or Ozempic? GLP-1 Fatigue, Dizziness and What Helps
By Dr. Moxit Shah, DM Endocrinology
Vishuddha Diabetes, Thyroid, Weight Loss Clinic, Ahmedabad
“Doctor, I started Mounjaro or Ozempic and my appetite has reduced—but why do I feel so tired?” It is an important question. GLP-1-based medicines can be valuable for medically supervised weight loss and blood sugar control, but persistent fatigue or dizziness deserves attention rather than being dismissed as a normal part of treatment.
Quick answer: Feeling tired during GLP-1 treatment may be related to reduced food intake, dehydration, nausea, changes in blood pressure, low blood glucose in certain medication combinations, or an unrelated medical condition. Fatigue is also a reported adverse effect in clinical trials. The right response depends on the cause; it is not always necessary—or safe—to increase or stop the medicine yourself.
Can Mounjaro, Ozempic or Wegovy cause fatigue?
Yes, some patients report tiredness, low energy or dizziness while taking GLP-1-based treatments such as semaglutide (Ozempic or Wegovy) or tirzepatide (Mounjaro). Tirzepatide is a dual GIP/GLP-1 receptor agonist, not a GLP-1-only medicine.
In US clinical trials for weight reduction, fatigue-related symptoms were reported in approximately 5–7% of tirzepatide-treated participants, compared with 3% receiving placebo. These figures do not mean that every episode of fatigue is caused by the medicine or that individual patients will have the same experience.
Read the current tirzepatide prescribing information for detailed safety data.
Seven possible reasons for tiredness or dizziness on GLP-1 treatment
1. You are eating much less than your body needs
Appetite suppression is part of how these medicines work. But some people inadvertently skip meals or consume too little food. If total energy intake drops substantially, weakness, poor concentration and reduced exercise tolerance can follow. The goal is healthier eating and sustainable weight loss, not prolonged undereating.
2. Protein intake may be inadequate
Small portions can make it harder to meet protein needs. During weight reduction, adequate protein and muscle-strengthening exercise help limit loss of lean mass. Suitable Indian choices may include curd, paneer, tofu, dal, soy foods and other protein-rich foods according to individual tolerance and preferences. Patients with chronic kidney disease may require different protein recommendations.
Learn more in our GLP-1 and muscle preservation guide.
3. Dehydration from nausea, vomiting or poor fluid intake
GLP-1 therapies can produce gastrointestinal side effects, especially when treatment is initiated or doses are increased. Nausea, vomiting and diarrhoea can reduce fluid intake or increase fluid losses. Symptoms can include thirst, reduced urine output, dark urine, dizziness or unusual weakness. Significant dehydration can also affect kidney function.
If you cannot keep fluids down, have very little urine or feel faint, seek prompt medical assessment.
4. Low blood glucose—particularly with insulin or certain diabetes tablets
GLP-1-based medicines alone generally carry a low risk of clinically significant hypoglycaemia. The risk becomes more important when they are taken with insulin or medicines such as gliclazide or glimepiride. Low glucose may cause sweating, trembling, hunger, confusion, weakness or dizziness.
If you have diabetes and experience these symptoms, check your glucose promptly when possible. If glucose is below 70 mg/dL and you are awake and able to swallow, use your prescribed hypoglycaemia action plan; a common approach is 15 g of fast-acting carbohydrate and rechecking after 15 minutes. Severe confusion, seizure or inability to swallow requires emergency care.
For further information, see our article on GLP-1 medicines and low blood sugar.
5. Blood pressure may have fallen
Weight reduction and changes in food or fluid intake can affect blood pressure. Some patients—especially those already taking blood-pressure medicines—may experience light-headedness on standing. A seated and standing blood-pressure assessment, medication review and hydration evaluation may be appropriate. Do not change prescription doses without clinical guidance.
6. Dose escalation may be moving faster than you tolerate
GLP-1 and GIP/GLP-1 treatments often start at a lower dose and are gradually increased to improve tolerability. Symptoms occurring after a dose change should be discussed with the prescriber. Depending on the medicine, its label and your condition, the clinician may consider additional time at the current dose or another adjustment. Never escalate the dose to speed up weight loss.
7. Another health problem may be contributing
Fatigue should not automatically be blamed on GLP-1 therapy. Anaemia, thyroid disorders, poor sleep, sleep apnoea, vitamin deficiencies, infection, depression and other conditions may contribute. If symptoms are persistent or disproportionate, a medical assessment may include an examination and selected tests based on your history.
Practical ways to maintain energy during GLP-1 weight-loss treatment
- Plan small, regular meals: avoid unintentionally going all day without adequate nutrition.
- Include protein: add an appropriate protein source to each meal; the amount depends on your health, body composition and kidney function.
- Hydrate consistently: sip water regularly, especially when feeling nauseated; fluid targets should be individualized for people with heart or kidney problems.
- Move gently and build strength: walking plus appropriate resistance exercise can support fitness and lean-mass preservation.
- Track symptoms: note whether fatigue begins after a dose change, a missed meal, vomiting, or a possible blood pressure or glucose drop.
- Review your treatment: speak with your endocrinologist if symptoms are persistent, worsening or interfering with normal activities.
For Indian meal examples, read What to Eat While Taking GLP-1 Medicines.
When should you seek urgent medical attention?
Get urgent help if you experience fainting, severe confusion, chest pain, difficulty breathing, persistent vomiting, inability to keep fluids down, very little urine, or severe and persistent abdominal pain (particularly if it radiates to the back). These symptoms can indicate conditions that need prompt evaluation.
Fatigue accompanied by rapidly worsening weakness, significant dehydration or repeated low glucose readings should never be managed by simply waiting for the next routine appointment.
Frequently asked questions
Is fatigue normal in the first few weeks of Mounjaro or Ozempic?
Some patients report fatigue early in treatment or following dose increases. However, symptoms have several possible causes. Persistent, severe or progressive tiredness should be reviewed rather than assumed to be harmless.
Should I stop my GLP-1 medicine if I feel tired?
Do not independently stop, restart or change the dose based only on tiredness. Contact the prescribing clinician for an assessment. Seek emergency care for severe warning signs.
Can GLP-1 medicines cause low blood sugar without insulin?
Clinically important hypoglycaemia is less common without insulin or sulfonylureas, but risk varies with the patient, underlying diabetes and combination treatment. Check glucose when symptoms suggest hypoglycaemia.
Will eating more protein solve fatigue?
Protein is important for nutrition and muscle preservation, but it will not correct all causes of fatigue. Dehydration, insufficient total calories, hypoglycaemia, low blood pressure and unrelated medical conditions may require specific management.
Do I need vitamin supplements while taking a GLP-1 medicine?
Not everyone needs supplements. If food intake is restricted or deficiencies are suspected, discuss nutrition assessment and targeted testing with your healthcare professional rather than taking multiple supplements without a reason.
GLP-1 and medical weight-loss care in Ahmedabad
Medical weight loss should improve health and function—not leave patients continuously weak or unwell. Dr. Moxit Shah, DM Endocrinology, at Vishuddha Diabetes, Thyroid, Weight Loss Clinic offers individualized assessment and follow-up for people considering or already receiving GLP-1-based treatment.
Clinic address: 104–105, Elite Magnum, Bhuyangdev Cross Road, Opp. Utsav Elegance, Vardhmannagar Society, Ghatlodiya, Memnagar, Ahmedabad, Gujarat 380061, India.
Appointments: +91 99799 92797.
Medical sources
- Tirzepatide (Zepbound) US prescribing information: adverse reactions, hypoglycaemia, gastrointestinal and volume-depletion precautions.
- Semaglutide (Wegovy) US prescribing information: safety and patient monitoring.
- American Diabetes Association: Pharmacologic Treatment of Obesity in Adults: nutrition, protein intake and resistance exercise during weight reduction.
Medical disclaimer: This article is for general patient education. Medicine approvals, brand indications and prescribing information can differ between India and other countries. This information does not replace diagnosis, individualized treatment or emergency medical care.
